Market Overview

UPDATE: KeyBanc Capital Markets Downgrades Xylem on Balance Risk-Reward


In a report published Wednesday, KeyBanc Capital Markets analyst Matt J. Summerville downgraded the rating on Xylem (NYSE: XYL) from Buy to Hold, and named a $29.00 price target.

In the report, KeyBanc Capital Markets noted, “We are reducing our rating on shares of Xylem, Inc. from BUY to HOLD as recent upward movement in the share price has led us to conclude the risk-reward is fairly balanced and in recognition that some of the gap in valuation between it and its peers has also closed.”

Xylem closed on Tuesday at $32.53.

Latest Ratings for XYL

Oct 2020Credit SuisseMaintainsUnderperform
Oct 2020Raymond JamesMaintainsOutperform
Jul 2020Credit SuisseMaintainsUnderperform

View More Analyst Ratings for XYL
View the Latest Analyst Ratings


Related Articles (XYL)

View Comments and Join the Discussion!

Posted-In: KeyBanc Capital Markets Matt J. SummervilleAnalyst Color Downgrades Analyst Ratings

Latest Ratings

YEXTDA DavidsonMaintains20.5
BYDB of A SecuritiesMaintains47.0
SAICMorgan StanleyMaintains98.0
PVHMorgan StanleyMaintains104.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at